Cogentix Medical Reports 83% Second Quarter Revenue Growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Roth Capital Upgrades Cogentix Medical (CGNT) to Buy
November 5, 2015 7:24 AM ESTRoth Capital upgraded Cogentix Medical (NASDAQ: CGNT) from Neutral to Buy with a price target of $3.00 (from $1.85).
Analyst Chris Lewis commented, "Given our confidence for CGNT to sustain double-digit revenue growth with opportunities for acceleration as EndoSheath sales productivity materializes, paired with notable... More
Cogentix Medical (CGNT) Misses Q2 EPS by 2c
November 3, 2015 4:51 PM ESTCogentix Medical (NASDAQ: CGNT) reported Q2 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $11.8 million versus the consensus estimate of $11.45 million.
Cogentix Medical sees FY2015 revenue of $49-51 million, versus the consensus of $50.0 million.
For earnings... More
